Share on LinkedInShare on LinkedIn

ARTICLE · 19 JUNE 2018

CCPC Confirms That Irish Pharmaceutical Sector Under Review Following Pricing Concerns

There have been reports in PaRR today that a spokesperson for the CCPC in Ireland has confirmed that the pharmaceutical sector in Ireland is being monitored following concerns raised regarding pricing issues.

IrelandAntitrust/Competition Law

There have been reports in PaRR today that a spokesperson for the Competition and Consumer Protection Commission (“CCPC”) in Ireland has confirmed that the pharmaceutical sector in Ireland is being monitored following concerns raised regarding pricing issues.  The CCPC also confirmed that this monitoring could give rise to potential enforcement action.  PARR also reported that chiefs of competition authorities across Europe met earlier this year to discuss excessive pricing in the pharmaceutical sector.  The CCPC has previously coordinated with authorities across Europe in taking enforcement action, for example in 2015 it coordinated with France, Italy and Sweden in a hotel booking investigation involving Booking.com.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from